Mikkelsen SU et al. Safety and efficacy of combination therapy of interferon-alpha2 + JAK1-2 inhibitor in the Philadelphia-negative chronic myeloproliferative neoplasms. Preliminary results from the Danish Combi-Trial — An open label, single arm, non-randomized multicenter Phase II study. Proc ASH 2015;Abstract 824.